日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial

新辅助改良FOLFIRINOX方案联合纳武利尤单抗治疗临界可切除胰腺导管腺癌:一项I期试点试验

Wainberg, Zev A; Link, Jason M; Premji, Alykhan; Zheng, Serena; Srienc, Michael; Hammons, McKensie; Kim, Shineui E; Li, Luyi; Liu, Zeyu; Tsvetkova, Olga; Abt, Evan R; Rosen, Lee; Kim, Stephen; King, Jonathan; Hines, O Joe; Girgis, Mark; Sadeghi, Saeed; Olevsky, Olga; Wong, Deborah; Yonemoto, Lisa; Siney, Ann Marie; Kelly, Kim; Kivork, Christine; Tseng, Chi-Hong; Radu, Caius G; Dawson, David W; Donahue, Timothy R

The importance of learning from people with lived experiences of eating disorders

向有饮食障碍亲身经历的人学习的重要性

Asaria, Alykhan

Neoadjuvant stereotactic body vs conventionally fractionated radiation therapy for borderline resectable and locally advanced pancreatic cancer: a propensity score-matched analysis

新辅助立体定向体部治疗与常规分割放射治疗治疗临界可切除和局部晚期胰腺癌:倾向评分匹配分析

Shimizu, Takayuki; Zheng, Serena; Maeda, Shimpei; Link, Jason; Deranteriassian, Aletta; Premji, Alykhan; King, Johathan; Girgis, Mark; Hines, Oscar Joe; Wainberg, Zev; Raldow, Ann; He, Jin; Burns, William; Narang, Amol; Qadan, Motaz; Castillo, Carlos Fernandez-Del; Lillemoe, Keith D; Wo, Jennifer; Hong, Theodore; Donahue, Timothy R

Report cards and outcome measurements to improve the safety of surgical care (North America): an updated systematic review from Making Healthcare Safer IV

报告卡和结果测量在提高外科手术安全性方面的应用(北美):来自《使医疗保健更安全 IV》的最新系统评价

Huy, Tess; Blegen, Mariah B; Tupper, Haley; Premji, Alykhan; Motala, Aneesa; Lawson, Emily; Shekelle, P G; Girgis, Mark; Maggard-Gibbons, M

Improving eating disorder care for underserved groups: a lived experience and quality improvement perspective

改善弱势群体饮食失调症护理:一种生活经验和质量改进视角

Asaria, Alykhan

Broad considerations for improving eating disorder care: a lived experience and quality improvement perspective

改善饮食失调症护理的广泛考量:基于亲身经历和质量改进的视角

Asaria, Alykhan

A Response to: Letter to the Editor Regarding "Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis"

对以下文章的回应:致编辑的信,主题为“比较南非基于培哚普利、依那普利或氯沙坦的抗高血压治疗方案的心血管结果和成本:真实世界医疗索赔数据库分析”

Snyman, Jacques R; Gumedze, Freedom; Jones, Erika S W; Alaba, Olufunke A; Tsabedze, Nqoba; Vira, Alykhan; Ntusi, Ntobeko A B

Vaccine Dispensing in a Section of the Private Healthcare Sector in South Africa (2017-2021)

南非私营医疗保健部门部分疫苗分发情况(2017-2021 年)

Truter, Ilse; Hugo, Johan; Smith, Hank; Bansal, Shailav; Vira, Alykhan

Ranolazine in Persistent Atrial Fibrillation: Evidence From a Case Series of Cardioversions

雷诺嗪治疗持续性房颤:来自一系列心脏复律病例的证据

Raman, Sagarika; Rutherford, Philip; Presslie, Calum; Thomas, Honey; Bandali, Alykhan; Das, Moloy

Medications for Opioid Use Disorder for Youth: Patient, Caregiver, and Clinician Perspectives

青少年阿片类药物使用障碍的药物治疗:患者、照护者和临床医生的视角

Buchholz, Connor; Bell, Lauren A; Adatia, Safina; Bagley, Sarah M; Wilens, Timothy E; Nurani, Alykhan; Hadland, Scott E